Nosocomial spread of human immunodeficiency virus-related multidrug- resistant tuberculosis in Buenos Aires

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 637-642

  Ritacco, Viviana ^a   Di Lonardo, Marta ^b   Reniero, Ana ^b   Ambroggi, Marta ^b   Barrera, Lucía ^b   Dambrosi, Alicia ^b   Lopez, Beatriz ^b   Isola, Nelida ^b   De Kantor, Isabel N ^b  

^a INPPAZ (PAHO/WHO)   (Argentina)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARGENTINA; ARTICLE; BACTERIUM ISOLATION; FEMALE; FREQUENCY ANALYSIS; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STRAIN DIFFERENCE; SURVIVAL RATE; TUBERCULOSIS; URBAN POPULATION;

EID: 0030790311     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514084     Document Type: Article

References (24)

1. Kantor IN, Ritacco V, Barrera L. Is multidrug-resistant tuberculosis an emerging infection in Buenos Aires? [in Spanish]. Medicina (B Aires) 1996;56:102-4.
2. Instituto Nacional de Epidemiologia "Emilio Coni." Análisis de la morbilidad por tuberculosis en la República Argentina. Tendencia 1980-94. Santa Fe, Argentina: INEEC, 1995:1-29; document no. EP-TB 29/95.
3. Instituto Nacional de Epidemiología "Emilio Coni." Asociación tuberculosis y HIV, análisis de la información disponible. Santa Fe, Argentina: INEEC, 1995:1-8; document no. EP-TB 31/95.
4. Programa Nacional de Lucha Contra los Retrovirus del Humano y SIDA. Perfil epidemiológico en la Argentina, periodo 1982-96. Actualizaciones SIDA 1996;4:125-33.
5. Reniero A, Ritacco V, Beltrán M. Análisis genómico de cepas de Mycobacterium tuberculosis aisladas de pacientes con y sin infección por HIV. Medicina (B Aires) 1994;54:469-70.
6. Argentine Commission on Tuberculosis Bacteriology and Tuberculosis Laboratory Network. Surveillance of antituberculous drug resistance in Argentina [summary]. Tubercle Lung Dis 1995;76(suppl 2):97.
7. Aita J, Barrera L, Reniero A, et al. Hospital transmission of multidrug-resistant Mycobacterium tuberculosis in Rosario, Argentina. Medicina (B Aires) 1996;56:48-50.
8. Morcillo N, Alito A, Romano M, et al. DNA fingerprinting analysis of a multidrug resistant tuberculosis outbreak in Buenos Aires. Medicina (B Aires) 1996;56:48-50.
9. Di Lonardo M, Isola NC, Ambroggi M, Rybko A, Poggi S. Mycobacteria in HIV-infected patients in Buenos Aires. Tubercle Lung Dis 1995;76:185-9.
10. Wayne LG. Mycobacterial speciation. In: Kubica GP, Wayne LG, eds. The mycobacteria: a source-book. Part A. New York: Marcel Dekker, 1984:25-65.
11. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull WHO 1969;41:21-43.
12. van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9.
13. van Soolingen D, Haas PEW, Hermans PWM, van Embden J. DNA fingerprinting of Mycobacterium tuberculosis. Methods Enzymol 1993;235:196-205.
14. Coronado VG, Beck-Sague CM, Hutton MD, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 1993;168:1052-5.
15. Fischl MA, Uttamchandani RB, Daikos GKL, et al. An outbreak of tuberculosis caused by multiple-drug resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992;117:177-83.
16. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:1514-21.
17. Valway SE, Greifinger RB, Papania M, et al. Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis 1994;170:151-6.
18. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR Morb Mortal Wkly Rep 1994;43(RR-13):33-4.
19. International Union against Tuberculosis and Lung Diseases and Tuberculosis Programme of the World Health Organization. Control of tuberculosis transmission in health care settings. Tubercle Lung Dis 1994;75:94-5.
20. Bifani PJ, Plikaytis BB, Kapur V, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996;275:452-7.
21. Frieden TR, Sherman LS, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis. JAMA 1996;276:1229-35.
22. Small PM, McClenny NB, Singh SP, Schoolnik GK, Tompkins LS, Mickelsen PA. Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol 1993;31:1677-82.
23. Wurtz R, Demarais P, Trainor W, et al. Specimen contamination in mycobacteriology laboratory detected by pseudo-outbreak of multidrug resistant tuberculosis: analysis by routine epidemiology and confirmation by molecular technique. J Clin Microbiol 1996;34:1017-9.
24. Frieden TR, Woodley CL, Crawford JT, Lew D, Dooley SM. The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error. Tubercle Lung Dis 1996;77:407-13.